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ABSTRACT 
Background 
The meniscus plays an important role in controlling the complex biomechanics of knee. Meniscus injury is 
common in knee joint. A perimeniscal capillary plexus supplies the outer meniscus, whereas the inner 
meniscus is composed of avascular tissue. Angiogenesis factor, such as vascular endothelial growth factor 
(VEGF) has important roles in promoting vascularization of various tissues. VEGF-mediated 
neovascularization is beneficial to the healing of injured tissues. However, the distribution and angiogenic role 
of VEGF remain unclear in meniscus and injured meniscus. We hypothesized that VEGF can affect meniscus 
cells and modulate healing process of meniscus.  
Methods 
Meniscus was obtained from total knee arthroplasty patients. Meniscal injury was created by a microsurgical 
blade. VEGF expression was investigated by polymerase chain reaction and immunohistochemical analyses. 
Results 
PCR results showed that in meniscal tissue, VEGF expression was undetected, whereas VEGF expressions 
were found in injured meniscal tissue (outer > inner). Immunohistochemical analyses revealed that VEGF 
was mainly detected in outer and around injured areas of meniscus. However, VEGF concentration was 
similar between inner meniscus-derived conditioned medium and outer meniscus-derived medium.  
Conclusions 
This study demonstrated that both inner and outer regions of meniscus contained VEGF. VEGF deposition 
was highly detected in injured meniscus. Our results suggest that VEGF may be preserved in extracellular 
matrix as the healing stimulator of damaged meniscus, especially in outer meniscus.  
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INTRODUCTION 
The meniscus is a fibrocartilaginous tissue that plays an important role in controlling complex biomechanics 
of knee. Proper functioning of meniscus depends on the composition and organization of its extracellular 
matrix ECM)(1). In adult human meniscus, only outer 10–25% of meniscus is vascular area, whereas inner 70–
80% of the meniscus is composed of avascular tissue(2). Cells in the vascularized area(red-red region) are 
more fibroblast-like in appearance, while cells in the middle(white-red region) and inner(white-white region) 
zones show more chondrocyte-like shapes. Based on these findings, several authors demonstrate that healing 
potential of outer meniscus is higher than that of inner meniscus(3). According to the injured area and severity 
of meniscal injury, meniscal healing rate is between 67% and 92%(4). Previous studies demonstrate that 
vascularization is a key factor on healing of injured meniscus, so outer meniscus has a better healing effect 
than inner meniscus(5).  
Vascular endothelial growth factor(VEGF) is a major angiogenesis factor. VEGF can promote both 
physiology and pathological vascularization(6). The effect of VEGF on vascular endothelial cells has been 
expanded to include migration and invasion into the basement membrane, proliferation, survival and the 
formation of fenestrations(7). Several researchers have demonstrated that VEGF can help the healing of tissues, 
such as knee ligament(8) and cornea(9) by promoting vascularization. In rabbit, VEGF expression in avascular 
zone shows a significant increase 2 weeks after injury. This increased expression of VEGF may lead to 
healing of meniscal tear and be attributed to a possible increase in expression of antiangiogenic factors, 
notably endostatin(10). However, the role and distribution of VEGF in human meniscus is unclear. In this study, 
we investigated the localization of VEGF in human meniscus and ex vivo meniscal injury model. 
 
METHODS 
Tissue, cells, and cell culture 
Institutional Review Board approval and informed consent were obtained before all experimental studies. 
Macroscopically intact lateral menisci were obtained at total knee arthroplasty in patients suffering from 
osteoarthritis of the knee. Patients(four females, two males) were 69, 70, 72, 73, 76, and 78 years of age. 
Cases that maintained sufficient articular cartilage of lateral femoral condyle and undegenerated lateral 
meniscus in magnetic resonance imaging were selected. Meniscal tissues were divided into two groups: native 
meniscus and injured meniscus. In the native meniscus group, inner and outer meniscus cells were prepared 
from the meniscal samples as described(11, 12). In brief, synovial/capsular tissues and the superficial zones of 
the menisci were removed carefully. The width of obtained lateral meniscus was 10–14 mm. The midpoint of 
meniscal width(5–7 mm in length from inner edge) was marked. Inner and outer meniscal tissues were 
prepared by careful cutting. Inner and outer meniscus cells were prepared by organ culture treatment. 
Attached cells(passage 0) were maintained with Dulbecco’s modified Eagle’s medium(DMEM, Wako, Osaka, 
Japan) containing 10% fetal bovine serum(FBS; HyClone, South Logan, UT), and 1% 
penicillin/streptomycin(Sigma). Meniscus cells between passages 1 and 2 were used.  
In the injured meniscus group, the lesions were created with a microsurgical blade: a full-thickness, 
longitudinal, 5-mm-long lesions in both inner and outer meniscal area. After that, we divided the injured tissue 
into two groups: one group was for immunohistochemistry assay, and another group was separated into inner 
2/3 and outer 1/3 meniscus for PCR and cells culture. 14 days later, we obtained the injured meniscal tissue 
from the first group to procced the immunohistochemistry assay.  When 80% of the petri dish was covered 
with cells, we selected the suitable tissues to extract RNA for tissue RT-RNA assay.  The cells were continued 
to culture. And the injured meniscus cells between passages 1 and 2 were used for RT-PCR. 
RT-PCR and quantitative real-time PCR 
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RNA samples were obtained from superficial zone-excluded meniscal tissues and cultured meniscus cells. 
Total RNAs were isolated using ISOGEN reagent(Nippon Gene, Toyama, Japan). RNA samples(500 ng) were 
reverse-transcribed with ReverTra Ace(Toyobo, Osaka, Japan). The cDNAs underwent PCR amplification in 
the presence of specific primers using exTaq DNA polymerase(TaKaRa, Ohtsu, Japan). For all the RT-PCR 
fragments, the reaction was allowed to proceed for 32-36 cycles. The following specific primer sets were 
used: VEGFexon3-4(5’-TGG TGG ACA TCT TCC AGG AG-3’ and 5’-TTG GTG AGG TTT GAT CCG CA-
3’)(13, 14), HIF-1α(5’-CAC TTC CAC ATA ATG TGA GTT CGC-3’ and 5’-GGT TCA CAA ATC AGC ACC 
AAG CAG G-3’)(15), and glyceraldehyde- 3-phosphate dehydrogenase(G3PDH)(16). Quantitative real-time 
PCR analyses were performed using a LightCycler ST-300 instrument(Roche Diagnostics, Mannheim, 
Germany) and FastStart DNA Master SYBR Green I kit(Roche Diagnostics) (17). The cycle number crossing 
the signal threshold was selected in the linear part of the amplification curve. Amplification data of G3PDH 
were used for normalization. These assays were run in triplicate, and relative mRNA levels were normalized 
with the level of non-stretched inner meniscus cells for every sample. 
Immunohistochemical assay 
The deposition of VEGF in the whole meniscal tissues including the superficial zones was assessed by 
immunohistochemical analyses using a rabbit anti-VEGF(sc-152) antibody(working dilution 1:100 for 
overnight incubation, Santa Cruz, CA). An anti-VEGF antibody(sc-152), raised against a peptide mapping at 
the N-terminus of VEGF-A of human origin, recognizes the precursor and mature form of human 
VEGF(mapping to 6p21.1). A bovine serum albumin solution without the primary antibody was used as a 
negative control. Staining density of VEGF was quantified by Image J 1.31. Relative staining densities of 
VEGF and VEGF-positive cells count(/2500um2) were assessed by mean values derived from five different 
images of meniscal bodies without the superficial zone of the menisci. Microscopic selection and evaluation 
of five different areas were performed by four observers.  
Statistical analysis 
All experiments were repeated in triplicate and similar results were obtained. Data were expressed as mean ± 
SD. Differences among groups were compared using the Mann–Whitney U-test. Significance was established 
at p < 0.05. 
 
RESULTS 
Gene expressions of VEGF and HIF-1α 
RT-PCR result showed, mRNA expressions of VEGF and HIF-1α, were not detected in freshly isolated inner 
or outer meniscal tissues. But in cultured cells, VEGF and HIF-1α mRNA could be detected in both inner and 
outer meniscal regions. In outer meniscal cells, more VEGF mRNA expression was observed(Fig. 1A). In 
Real-time PCR, VEGF and HIF-1α gene expression in meniscal tissue and cells were parallel with RT-
PCR(Fig. 1B, 1C). Nevertheless, VEGF and HIF-1α mRNA could be detected in both inner and outer cultured 
injured-meniscal tissue. More VEGF was detected in outer injured meniscal tissue.  Meanwhile, HIF-1α was 
detected in inner and outer injured meniscal tissue similarly(Fig. 2A). Real-time PCR showed a similar result 
with RT-PCR result(Fig. 2B, 2C).  
 
VEGF deposition in the meniscus 
In native meniscal tissue, VEGF was mainly detected in outer and superficial zones by immunohistochemical 
analyses (Fig. 3A and B). The deposition of VEGF was observed mainly in intracellular, pericellular, and 
extracellular regions of outer meniscus cells(Fig. 3B). In addition, VEGF was weakly detected in inner 
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meniscus cells(Fig. 3C). VEGF staining density and VEGF-positive cells count (/2500um2) were higher in 
outer region than inner meniscus(Fig. 3E, 3F).  
Moreover, in cultured injured meniscal tissue, VEGF was mainly detected around tear region(Fig. 4A, B and 
C), especially, deposition of VEGF was observed more highly in outer tear region(Fig. 4B) than cultured outer 
meniscal tissue(Fig. 4D). Moreover, around inner tear area, VEGF deposition arose(Fig. 4C). However, in 
cultured inner meniscus, VEGF deposition remained low lever(Fig. 4E). These results were parallel with PCR 
results. VEGF staining density and VEGF-positive cells count(/2500um2) were higher in the injured region 
than in the cultured meniscus(Fig. 4G, 4H). 
 
DISCUSSION：  
Hypoxia is an established feature in injured tissue and a key stimulus that induces transcription of VEGF(18). 
Hypoxia inducibility is conferred on VEGF gene by homologous sequences. A 28-base sequence has been 
identified in the 5′-promoter of rat and human VEGF gene, which mediates hypoxia-induced transcription(19, 
20). Hypoxia-inducible factor-1α(HIF-1α) is a key mediator of hypoxic responses. In hypoxia condition, HIF1-
α accumulates and binds to HIF1-β, thus forming active HIF1 complex that can initiate transcription(21). 
In response to hypoxia, accumulation of HIF-1α binds to specific enhancer elements, then recruits additional 
transcriptional factors such as P-CREB and P-STAT3, resulting in initiating VEGF gene transcription(21). 
Hypoxia induces binding of 5′ to the Hypoxia responsive element in VEGF gene promoter region, which in 
turn increases VEGF transcription(22). HIF-1α increased VEGF reporter expression in cells exposed to 1 or 20% 
O2 in a dose-dependent manner(23). Lacking HIF-1α, VEGF mRNA levels increased only slightly in response 
to hypoxia but not induced by hypoxia in cells(23).  
Besides the induction of transcription an post-transcription, hypoxia promotes stabilization of the VEGF 
mRNA by proteins that bind to sequences located in the 3′-untranslated region of the VEGF mRNA(24). 
Hypoxia can promote the half-life of VEGF mRNA from 43±6 min under normoxic condition to 106±9 
min(24). 
In this study, we detected the expressions of VEGF and HIF-1α mRNA in both inner and outer meniscus cells. 
This result is in accordance with the distribution of perimeniscal capillary plexus. It revealed that VEGF is 
concerned with meniscus vascularization. And in injured meniscus tissue, expressions of VEGF and HIF-1α 
mRNA arose, which were not found in native meniscus tissue. We consider the phenomenon is concerned 
with vascularization of injured meniscus and then promotes meniscal injury healing.  
VEGF exists at both inner and outer meniscus cells, but only outer region is vascular area. Angiogenesis is 
dependent on a balance between pro- and anti-angiogenic factors(25). VEGF expression in the adult is cell-
type-specific(26) and is controlled from transcription to translation, and is upregulated in tumors and various 
pathologic states(27). In vitro studies, VEGF can stimulate chondrocytes to proliferate and express MMP-13 via 
HIF1-α induction, MMP expression might be another factor which inhibits healing despite increased 
angiogenesis(28).  
In our study, we demonstrated that the expression of VEGF and HIF-1α was parallel. According that, we 
consider that VEGF is also stimulated by HIF-1α. However, HIF-1α and VEGF exist in the inner meniscus, it 
is still avascular tissue. The anti-angiogenic factors exist in human meniscus, and they may contribute to 
avascularization of inner meniscus. Fujii et al demonstrated that inner meniscus contained larger amounts of 
chondromodulin-I(ChM-I) than outer meniscus, and inner meniscus-derived ChM-I inhibited endothelial cell 
proliferation(29). In addition, the concentration of endostatin/collagen XVIII which is been demonstrated as an 
inhibitor of angiogenesis was higher in inner meniscus than outer meniscus(28). Endostatin/collagen XVIII can 
inactivate VEGF signal transduction pathways by MAPK Erk 1/2. This anti-angiogenic factor maintained 
avascular zones in cartilage and fibrocartilage(28). It may express our contradiction between VEGF distribution 
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and its angiogenic effect on both inner and outer menisci. Future research are needed for relationship between 
VEGF and anti-angiogenic factors.  
Neovascularization induced  by VEGF must be a high level(9), Phillips et al found VEGF implants(200ng to 
1000ng) consistently stimulated angiogenesis of rabbit cornea. We consider that in human meniscus, higher 
VEGF concentration is sufficient to cause the vascularization.  Our current study demonstrated that outer 
meniscus cells expressed higher VEGF detection, this phenomenon may also explain why outer meniscus is 
vascular but inner meniscus is not. The exact concentration of VEGF between inner and outer meniscus 
should be measured and compared. 
In our meniscal healing model immunostaining, cells counting for VEGF arose approximately 4 folds around 
injured area compared to uninjured area. We consider those cells are endothelial cells which can induce 
neovascularization to heal meniscus injury. Previous study found that not all of fibrochondrocytes were 
positively immunostained in meniscus, fibroblasts and myofibroblasts which are only encountered in injured 
menisci near the damaged site. These cells may not express VEGF(30). 
Limitations of our study are that we were not able to collect tissues from young or healthy individuals. The 
injury created by a microsurgical blade is not a real tear model. To limit chondrocyte dedifferentiation, we 
cultured chondrocytes over no more than 3 passages. 
In conclusion, our study demonstrates that meniscus contains VEGF in both inner and outer regions. VEGF 
deposition was highly detected in injured meniscus. Our results suggest that VEGF may be a key angiogenic 
factor for promoting the healing of meniscal injury, especially in the outer meniscus. 
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Figure captions： 
Figure 1. Expression of VEGF and HIF-1α mRNA in the superficial zone-excluded meniscal tissues and 
cultured meniscus cells. RT-PCR result(A) and Real-time PCR result (B, C). *p < 0.05.        
   
Figure 2. Expression of VEGF and HIF-1α mRNA in the native, cultured and injured meniscal tissues. RT-
PCR result(A) and Real-time PCR result(B, C). *p < 0.05. 
 
Figure 3. VEGF localization in native meniscus. Overview of radial section of lateral meniscus(A). VEGF 
deposition in outer and inner meniscus cells (B, C, brown). Arrows denote VEGF-positive meniscus cells. 
Control(D). VEGF staining density and VEGF-positive cells count(/2500um2)(E, F). Bars, 100 mm. *p < 0.05. 
 
Figure 4. VEGF localization in injured meniscus. Overview of radial section of injured meniscus(A). VEGF 
deposition around the tear area (B and C, brown). Arrows denote VEGF-positive meniscus cells. VEGF 
deposition in the inner and outer meniscus cells(D and E, brown). Control (F). VEGF staining density and 
VEGF-positive cells count (/2500um2)(G, H). Bars, 100 mm. *p < 0.05. 
 
 
 
 
 
 
